KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Other Non-Current Assets (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Other Non-Current Assets data on record, last reported at $1.1 billion in Q4 2025.

  • For Q4 2025, Other Non-Current Assets changed 0.44% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, changed 0.44%, while the annual FY2025 figure was $1.1 billion, 0.44% changed from the prior year.
  • Other Non-Current Assets reached $1.1 billion in Q4 2025 per ZBH's latest filing, up from $1.0 billion in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.2 billion in Q2 2024 and bottomed at $57.9 million in Q4 2021.
  • Average Other Non-Current Assets over 5 years is $1.0 billion, with a median of $1.1 billion recorded in 2024.
  • Peak YoY movement for Other Non-Current Assets: plummeted 94.03% in 2021, then skyrocketed 1838.17% in 2022.
  • A 5-year view of Other Non-Current Assets shows it stood at $57.9 million in 2021, then surged by 1838.17% to $1.1 billion in 2022, then increased by 2.66% to $1.2 billion in 2023, then dropped by 4.91% to $1.1 billion in 2024, then rose by 0.44% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $1.1 billion in Q4 2025, $1.0 billion in Q3 2025, and $1.0 billion in Q2 2025.